Target intelligence / Profile preview

SMARCAD1 divergent transcript (SMARCAD1-DT)

Target
SMARCAD1-DT
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

SMARCAD1 divergent transcript (SMARCAD1-DT) is a long non-coding RNA gene transcribed near the SMARCAD1 locus. Unlike SMARCAD1, which encodes a chromatin remodeling protein involved in epigenetic regulation and DNA repair, SMARCAD1-DT does not encode a protein and its biological roles, clinical relevance, and possible therapeutic utility are not currently established in public biomedical resources. It may have a regulatory role in the expression of neighboring genes, but its specific functions remain largely unknown in literature.

Other names
SMARCAD1-DTSMARCAD1 divergent transcript
02

Mechanism of action

None known; there are no drugs targeting SMARCAD1-DT specifically

03

Biological functions

Currently undefined in commonly curated public resources. SMARCAD1-DT, as a divergent transcript, may be involved in gene regulation at the SMARCAD1 locus, but its direct biological functions remain uncharacterized.
04

Disease associations

No direct disease association has been robustly reported for SMARCAD1-DT. Disease roles described in literature pertain to SMARCAD1, not SMARCAD1-DT.
05

Safety considerations

None known, as SMARCAD1-DT is not a therapeutic target and has not been linked to Interventional drug studies
06

Interacting drugs

None known
07

Biomarkers

None known or reported

Beyond the preview

Go deeper on SMARCAD1 divergent transcript (SMARCAD1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMARCAD1 divergent transcript (SMARCAD1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call